Residents with any information have been urged to contact the concerned authority
Johnson & Johnson's one-shot COVID-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration (FDA) staff said in documents published on Wednesday, paving the way for its approval for emergency use.
The FDA's panel of independent experts meets on Friday to decide whether to approve the shot. While it is not bound to follow the advice of its experts, the FDA did so when authorizing the Pfizer Inc and Moderna Inc vaccines.
J&J's vaccine was 66% effective in preventing COVID-19 against multiple variants in a global trial involving nearly 44,000 people, the company said last month.
Its effectiveness varied from 72% in the United States to 66% in Latin America and 57% in South Africa, where a new variant has spread, though the vaccine was 85% effective overall in stopping severe cases of the disease.
The vaccine was effective in reducing the risk of COVID-19 and preventing PCR-test confirmed COVID-19 at least 14 days after vaccination, the FDA said in its briefing documents.
Three vaccine recipients had severe side effects in the trial, but the FDA said that its analysis did not raise any specific safety concerns that would preclude issuance of an emergency use authorization.
J&J had not previously released details of its clinical trial data beyond efficacy rates.
Residents with any information have been urged to contact the concerned authority
Northeastern University in Boston says the action was taken after some protesters resorted to virulent anti-Semitic slurs
The church has been built on 4.37 acres of land, and stands opposite the BAPS Hindu temple
A detailed guide on where to apply, the steps involved, and criteria for eligibility
The Emirates called for strengthening the international humanitarian response and providing urgent relief to those in need
Photonics is the study of light and has several applications including LED, VR, holograms, high-speed internet and solar panels among other things
A delegation from Egypt arrived in Israel on Friday hoping to revive the truce negotiations
The decision aims to protect the safety and security of pilgrims